A Shift towards Pro-Inflammatory CD16+ Monocyte Subsets with Preserved Cytokine Production Potential after Kidney Transplantation

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Vereyken, Elly J F ^a   Kraaij, Marina D ^a   Baan, Carla C ^a   Rezaee, Farhad ^b   Weimar, Willem ^a   Wood, Kathryn J ^c   Leenen, Pieter J M ^a   Rowshani, Ajda T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BASILIXIMAB; CALCINEURIN INHIBITOR; CD14 ANTIGEN; CD16 ANTIGEN; CD40 ANTIGEN; CORTICOSTEROID; CREATININE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; MALE; MONOCYTE;

ADULT; AGED; ANTIGENS, SURFACE; CYTOKINES; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTRACELLULAR SPACE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE; RECEPTORS, IGG; YOUNG ADULT;

EID: 84880799648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070152     Document Type: Article

References (49)

1. Flechner SM, Kurian SM, Head SR, Sharp SM, Whisenant TC, et al. (2004) Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 4: 1475-1489.
2. Hancock WW, Thomson NM, Atkins RC, (1983) Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 35: 458-463.
3. Pietra BA, Wiseman A, Bolwerk A, Rizeq M, Gill RG, (2000) CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 106: 1003-1010.
4. Uehara S, Chase CM, Cornell LD, Madsen JC, Russell PS, et al. (2007) Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant 7: 57-65.
5. Wood KJ, Goto R, (2012) Mechanisms of rejection: current perspectives. Transplantation 93: 1-10.
6. Cao Q, Zheng D, Wang YP, Harris DC, (2011) Macrophages and dendritic cells for treating kidney disease. Nephron Exp Nephrol 117: e47-52.
7. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
8. Chadban SJ, Wu H, Hughes J, (2010) Macrophages and kidney transplantation. Semin Nephrol 30: 278-289.
9. Rowshani AT, Vereyken EJ, (2012) The role of macrophage lineage cells in kidney graft rejection and survival. Transplantation 94: 309-318.
10. Jose MD, Ikezumi Y, van Rooijen N, Atkins RC, Chadban SJ, (2003) Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 76: 1015-1022.
11. Qi F, Adair A, Ferenbach D, Vass DG, Mylonas KJ, et al. (2008) Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation 86: 1267-1274.
12. Ozdemir BH, Ozdemir AA, Sezer S, Colak T, Haberal M, (2011) Influence of 1,25-dihydroxyvitamin D3 on human leukocyte antigen-DR expression, macrophage infiltration, and graft survival in renal allografts. Transplant Proc 43: 500-503.
13. Hutchinson JA, Riquelme P, Sawitzki B, Tomiuk S, Miqueu P, et al. (2011) Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol 187: 2072-2078.
14. Wang Y, Wang YP, Zheng G, Lee VW, Ouyang L, et al. (2007) Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 72: 290-299.
15. Wilson HM, Chettibi S, Jobin C, Walbaum D, Rees AJ, et al. (2005) Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol 167: 27-37.
16. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
17. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74-80.
18. Weber C, Belge KU, von Hundelshausen P, Draude G, Steppich B, et al. (2000) Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol 67: 699-704.
19. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, et al. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 168: 3536-3542.
20. Shantsila E, Wrigley B, Tapp L, Apostolakis S, Montoro-Garcia S, et al. (2011) Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology. J Thromb Haemost 9: 1056-1066.
21. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, et al. (2011) SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118: e50-61.
22. Janols H, Bredberg A, Thuvesson I, Janciauskiene S, Grip O, et al. (2010) Lymphocyte and monocyte flow cytometry immunophenotyping as a diagnostic tool in uncharacteristic inflammatory disorders. BMC Infect Dis 10: 205.
23. Nahrendorf M, Pittet MJ, Swirski FK, (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121: 2437-2445.
24. Ulrich C, Heine GH, Gerhart MK, Kohler H, Girndt M, (2008) Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am J Transplant 8: 103-110.
25. Nockher WA, Scherberich JE, (1998) Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 66: 2782-2790.
26. Saionji K, Ohsaka A, (2001) Expansion of CD4+CD16+ blood monocytes in patients with chronic renal failure undergoing dialysis: possible involvement of macrophage colony-stimulating factor. Acta Haematol 105: 21-26.
27. Scherberich JE, Estner H, Segerer W, (2004) Impact of different immunosuppressive regimens on antigen-presenting blood cells in kidney transplant patients. Kidney Blood Press Res 27: 177-180.
28. Sester U, Sester M, Heine G, Kaul H, Girndt M, et al. (2001) Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment. Nephrol Dial Transplant 16: 1402-1408.
29. Girlanda R, Kleiner DE, Duan Z, Ford EA, Wright EC, et al. (2008) Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am J Transplant 8: 600-607.
30. Tinckam KJ, Djurdjev O, Magil AB, (2005) Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 68: 1866-1874.
31. Kirk AD, Hale DA, Mannon RB, Kleiner DE, Hoffmann SC, et al. (2003) Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 76: 120-129.
32. Kawanaka N, Nagake Y, Yamamura M, Makino H, (2002) Expression of Fc gamma receptor III (CD16) on monocytes during hemodialysis in patients with chronic renal failure. Nephron 90: 64-71.
33. Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, et al. (2011) CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J 32: 84-92.
34. Dayyani F, Belge KU, Frankenberger M, Mack M, Berki T, et al. (2003) Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytes. J Leukoc Biol 74: 33-39.
35. Fenton MJ, Vermeulen MW, Kim S, Burdick M, Strieter RM, et al. (1997) Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immun 65: 5149-5156.
36. Nagayama H, Sato K, Kawasaki H, Enomoto M, Morimoto C, et al. (2000) IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte-derived dendritic cells. J Immunol 165: 59-66.
37. Pietila TE, Veckman V, Kyllonen P, Lahteenmaki K, Korhonen TK, et al. (2005) Activation, cytokine production, and intracellular survival of bacteria in Salmonella-infected human monocyte-derived macrophages and dendritic cells. J Leukoc Biol 78: 909-920.
38. Sarhan D, D'Arcy P, Wennerberg E, Liden M, Hu J, et al. (2013) Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-gamma. Eur J Immunol 43: 249-257.
39. Abdallah AN, Billes MA, Attia Y, Doutremepuich C, Cassaigne A, et al. (1997) Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy. Eur Heart J 18: 1024-1029.
40. Kutukculer N, Shenton BK, Clark K, Rigg KM, Forsythe JL, et al. (1995) Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1. Transpl Int 8: 45-50.
41. De Serres SA, Vadivel N, Mfarrej BG, Grafals M, DeJoseph M, et al. (2011) Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation 91: 552-559.
42. Testro AG, Visvanathan K, Skinner N, Markovska V, Crowley P, et al. (2011) Acute allograft rejection in human liver transplant recipients is associated with signaling through toll-like receptor 4. J Gastroenterol Hepatol 26: 155-163.
43. Diaz JA, Booth AJ, Lu G, Wood SC, Pinsky DJ, et al. (2009) Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am J Transplant 9: 1773-1783.
44. Xie L, Ichimaru N, Morita M, Chen J, Zhu P, et al. (2012) Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance. Liver Transpl 18: 444-454.
45. Ring GH, Saleem S, Dai Z, Hassan AT, Konieczny BT, et al. (1999) Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts. Transplantation 67: 1362-1365.
46. Cartwright NH, Demaine AG, Hurlock NJ, McGonigle RJ, Rowe PA, et al. (2000) Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching. Transpl Immunol 8: 109-114.
47. Sadeghi M, Daniel V, Weimer R, Wiesel M, Hergesell O, et al. (2003) Pre-transplant Th1 and post-transplant Th2 cytokine patterns are associated with early acute rejection in renal transplant recipients. Clin Transplant 17: 151-157.
48. Suresh V, Carey BS, Shaw S, Tse WY, Cartwright N, et al. (2005) A retrospective study of the prognostic impact of cytokine secretion in mixed lymphocyte culture on long-term graft function following allogeneic renal transplantation. Transpl Int 18: 1067-1071.
49. Buob D, Hazan M, Homs S, Matignon M, Mansour H, et al. (2011) Intrarenal IFN-gamma mRNA expression differentiates clinical and subclinical glomerulitis in renal transplant recipients. Transplantation 92: 170-175.